Rapt Therapeutics, Inc.
Clinical trials sponsored by Rapt Therapeutics, Inc., explained in plain language.
-
Asthma drug trial halted early: RPT193 fails to show promise
Disease control TerminatedThis study tested an experimental drug called RPT193 in 38 adults with moderate-to-severe asthma that was not fully controlled by standard inhalers. The goal was to see if RPT193 could prevent asthma attacks and improve lung function. However, the trial was terminated early, mean…
Phase: PHASE2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
Eczema pill trial halted midway: what happened?
Symptom relief TerminatedThis study tested an experimental daily pill called RPT193 for adults with moderate-to-severe atopic dermatitis (eczema). The goal was to see if it could reduce skin redness, swelling, and itchiness over 16 weeks. The trial was terminated early, so results are limited. It involve…
Phase: PHASE2 • Sponsor: RAPT Therapeutics, Inc. • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC